Product details
Catalog number BNUB0809-100
Price for BNUB0809-100
Size / count 1x 100 µL
Recognizes a protein of 36 kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t (11; 14) (q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative) . Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
The catalog number for Cyclin D1 (CCND1/809), 0.2mg/mL is BNUB0809-100.
Cyclin D1 (CCND1/809), 0.2mg/mL is available in the following size(s): 1x 100 µL.
Cyclin D1 (CCND1/809), 0.2mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
Cyclin D1 (CCND1/809), 0.2mg/mL is manufactured by Biotium.
Estimated delivery time for Cyclin D1 (CCND1/809), 0.2mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for Cyclin D1 (CCND1/809), 0.2mg/mL is available here: https://cdn.gentaur.com/products/37/68dd029c061270361e1020ec/msds/bnub0809-100.pdf.
Recognizes a protein of 36 kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t
Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.
Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.
A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.